These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32086362)

  • 1. Quality indicators for advanced ovarian cancer surgery from the European Society of Gynaecological Oncology (ESGO): 2020 update.
    Fotopoulou C; Concin N; Planchamp F; Morice P; Vergote I; du Bois A; Querleu D
    Int J Gynecol Cancer; 2020 Apr; 30(4):436-440. PubMed ID: 32086362
    [No Abstract]   [Full Text] [Related]  

  • 2. European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer.
    Cibula D; Planchamp F; Fischerova D; Fotopoulou C; Kohler C; Landoni F; Mathevet P; Naik R; Ponce J; Raspagliesi F; Rodolakis A; Tamussino K; Taskiran C; Vergote I; Wimberger P; Zahl Eriksson AG; Querleu D
    Int J Gynecol Cancer; 2020 Jan; 30(1):3-14. PubMed ID: 31900285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter to the Editor on the "European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery" by Querleu et al, Int J Gynecol Cancer 2016;26: 1354-1363.
    Salehi S; Hjerpe E; Falconer H
    Int J Gynecol Cancer; 2018 Mar; 28(3):426-427. PubMed ID: 29384793
    [No Abstract]   [Full Text] [Related]  

  • 4. Quality of advanced ovarian cancer surgery: A French assessment of ESGO quality indicators.
    Gac MM; Loaec C; Silve J; Vaucel E; Augereau P; Wernert R; Bourgin C; Aireau X; Lortholary A; Descamps P; Priou F; Deblaye P; Bourgeois H; Delecroix V; Empereur F; Campion L; Classe JM
    Eur J Surg Oncol; 2021 Feb; 47(2):360-366. PubMed ID: 32863097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery.
    Querleu D; Planchamp F; Chiva L; Fotopoulou C; Barton D; Cibula D; Aletti G; Carinelli S; Creutzberg C; Davidson B; Harter P; Lundvall L; Marth C; Morice P; Rafii A; Ray-Coquard I; Rockall A; Sessa C; van der Zee A; Vergote I; du Bois A
    Int J Gynecol Cancer; 2016 Sep; 26(7):1354-63. PubMed ID: 27648648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innovations in surgery and peri-operative care: A technical gimmick or true oncology advance?
    Fotopoulou C; Krivak TC; Chang SJ
    Gynecol Oncol; 2021 Apr; 161(1):1-3. PubMed ID: 33762085
    [No Abstract]   [Full Text] [Related]  

  • 7. European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer Surgery.
    Querleu D; Planchamp F; Chiva L; Fotopoulou C; Barton D; Cibula D; Aletti G; Carinelli S; Creutzberg C; Davidson B; Harter P; Lundvall L; Marth C; Morice P; Rafii A; Ray-Coquard I; Rockall A; Sessa C; van der Zee A; Vergote I; duBois A
    Int J Gynecol Cancer; 2017 Sep; 27(7):1534-1542. PubMed ID: 30814245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of ovarian cancer surgery quality indicators using a modified Delphi approach.
    Gagliardi AR; Fung MF; Langer B; Stern H; Brown AD
    Gynecol Oncol; 2005 May; 97(2):446-56. PubMed ID: 15863144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When and Who Should Perform Epithelial Ovarian Cancer Surgery?
    Escayola C; Torrent JJ; Ferron G; Quenet F; Querleu D
    Int J Gynecol Cancer; 2018 Mar; 28(3):594-599. PubMed ID: 29303937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quality control of the surgical management of advanced ovarian carcinoma].
    Pomel C; Lecuru F; Rouzier R; Dauplat J; Ferron G
    J Gynecol Obstet Biol Reprod (Paris); 2012 Feb; 41(1):3-5. PubMed ID: 22192233
    [No Abstract]   [Full Text] [Related]  

  • 11. Quality control in ovarian cancer surgery.
    Hacker NF
    Ann Oncol; 2011 Dec; 22 Suppl 8():viii19-viii22. PubMed ID: 22180394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of care in surgery for ovarian cancer in Europe.
    Verleye L; Vergote I; van der Zee AG
    Eur J Surg Oncol; 2010 Sep; 36 Suppl 1():S108-14. PubMed ID: 20580524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model.
    Aletti GD; Santillan A; Eisenhauer EL; Hu J; Aletti G; Podratz KC; Bristow RE; Chi DS; Cliby WA
    Gynecol Oncol; 2007 Oct; 107(1):99-106. PubMed ID: 17602726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In the wake of the 2017 ASCO meetings, the surgical strategy for ovarian cancer remains on track.
    Villet R
    J Visc Surg; 2018 Apr; 155(2):89-90. PubMed ID: 29622406
    [No Abstract]   [Full Text] [Related]  

  • 15. Quality indicators in ovarian cancer surgery: report from the French Society of Gynecologic Oncology (Societe Francaise d'Oncologie Gynecologique, SFOG).
    Querleu D; Ray-Coquard I; Classe JM; Aucouturier JS; Bonnet F; Bonnier P; Darai E; Devouassoux M; Gladieff L; Glehen O; Haie-Meder C; Joly F; Lécuru F; Lefranc JP; Lhommé C; Morice P; Salengro A; Stoeckle E; Taieb S; Zeng ZX; Leblanc E
    Ann Oncol; 2013 Nov; 24(11):2732-9. PubMed ID: 23857961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unplanned 30-day hospital readmission as a quality measure in gynecologic oncology.
    Wilbur MB; Mannschreck DB; Angarita AM; Matsuno RK; Tanner EJ; Stone RL; Levinson KL; Temkin SM; Makary MA; Leung CA; Deutschendorf A; Pronovost PJ; Brown A; Fader AN
    Gynecol Oncol; 2016 Dec; 143(3):604-610. PubMed ID: 27665313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer?
    Eisenkop SM; Spirtos NM
    Gynecol Oncol; 2001 Sep; 82(3):489-97. PubMed ID: 11520145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a structured quality management program on surgical outcome in primary advanced ovarian cancer.
    Harter P; Muallem ZM; Buhrmann C; Lorenz D; Kaub C; Hils R; Kommoss S; Heitz F; Traut A; du Bois A
    Gynecol Oncol; 2011 Jun; 121(3):615-9. PubMed ID: 21414656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reporting 'Denominator' data is essential for benchmarking and quality standards in ovarian cancer.
    Phillips A; Balega J; Nevin J; Singh K; Elattar A; Kehoe S; Sundar S
    Gynecol Oncol; 2017 Jul; 146(1):94-100. PubMed ID: 28411948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical management of recurrent ovarian cancer: the advantage of collaborative surgical management and a multidisciplinary approach.
    Burton E; Chase D; Yamamoto M; de Guzman J; Imagawa D; Berman ML
    Gynecol Oncol; 2011 Jan; 120(1):29-32. PubMed ID: 21055797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.